Abstract
Contrast-enhanced spectral mammography (CESM) provides low-energy 2D mammographic images comparable to standard digital mammography and a post-contrast recombined image to assess tumor neovascularity similar to magnetic resonance imaging (MRI). The utilization of CESM in the United States is currently low but could increase rapidly given many potential indications for clinical use. This article discusses historical background and literature review of indications and diagnostic accuracy of CESM to date. CESM is a growing technique for breast cancer detection and diagnosis that has levels of sensitivity and specificity on par with contrast-enhanced breast MRI. Because of its similar performance and ease of implementation, CESM is being adopted for multiple indications previously reserved for MRI, such as problem-solving, disease extent in newly diagnosed patients, and evaluating the treatment response of neoadjuvant chemotherapy. (C) 2018 Elsevier Inc. All rights reserved.
Original language | English |
---|---|
Pages (from-to) | 70-79 |
Number of pages | 10 |
Journal | Seminars in Ultrasound Ct and Mri |
Volume | 39 |
Issue number | 1 |
DOIs | |
Publication status | Published - 1 Feb 2018 |
Keywords
- FIELD DIGITAL MAMMOGRAPHY
- BREAST-CANCER RISK
- SCREEN-FILM MAMMOGRAPHY
- TUMOR SIZE
- NEOADJUVANT CHEMOTHERAPY
- DIAGNOSTIC PERFORMANCE
- PATIENT PREFERENCES
- RADIATION-EXPOSURE
- MRI
- POPULATION